RecruitingNCT03794076
Official study titleCromoglicte Adjunctive Therapy for Outpatients With Schizophrenia
In PittsburghSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Vishwajit Nimgaonkar, MD PhD
RecruitingNCT06257056
Official study titleClosed Loop Neuromodulation for Treatment-refractory Schizophrenia: A Pilot Study
In DallasSchizophreniaDevice studyAges 22–70
- Countries
- United States
- Sponsor
- Bradley Lega
RecruitingNCT05830903
In TaipeiSchizophreniaBehavioural studyAges 20–40
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
RecruitingNCT03911726
Official study titleDo Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
In MannheimSchizophreniaInterventional studyAges 18–65
- Countries
- Germany
- Sponsor
- Central Institute of Mental Health, Mannheim
RecruitingNCT06574360
In TaichungSchizophreniaMedication studyAges 18–65
- Countries
- Taiwan
- Sponsor
- China Medical University Hospital
RecruitingNCT05052853
In TaichungSchizophreniaMedication studyAges 13–45
- Countries
- Taiwan
- Sponsor
- China Medical University Hospital
RecruitingNCT05296720
In StrasbourgSchizophreniaBehavioural studyAges 18–60
- Countries
- France
- Sponsor
- Centre Psychothérapique de Nancy
RecruitingNCT04267003
Official study titleTranscranial Direct Current Stimulation (tDCS) Studies of Cognition, Oscillations and GABA Levels in Schizophrenia
In SacramentoSchizophreniaDevice studyAges 18–47
- Countries
- United States
- Sponsor
- University of California, Davis
RecruitingNCT07557368
Official study titleEffects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia: A Randomized Controlled Trial[
In ShanghaiSchizophreniaInterventional studyAges 18–45
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
RecruitingNCT03817502
What is this study about?Researchers are comparing Cariprazine and placebo to find out how the approaches affect psychotic symptoms in young people with schizophrenia.
Multiple locations, including SofiaSchizophreniaMedication studyAges 13–17
- Countries
- United States, Bulgaria, Colombia, + 5 others
- Sponsor
- Gedeon Richter Plc.
RecruitingNCT06888726
Official study titleEfficacy of High-Intensity Transcranial Alternating Current Stimulation (Hi-tACS) in Treating Negative Symptoms of Schizophrenia
In ShanghaiSchizophreniaDevice studyAges 18+
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
RecruitingNCT07227818
What is this study about?This study evaluates the safety and effectiveness of NBI-1117568 for people with schizophrenia.
Multiple locations, including Garden GroveSchizophreniaMedication studyAges 18–65
- Countries
- United States, Serbia
- Sponsor
- Neurocrine Biosciences (Biotech company)
Data coveragePublic registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.